Literature DB >> 12941884

Identification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus.

Hong-Yi Pan1, Yan-Jin Zhang, Xin-Ping Wang, Jian-Hong Deng, Fu-Chun Zhou, Shou-Jiang Gao.   

Abstract

The latent nuclear antigen (LNA) of Kaposi's sarcoma-associated herpesvirus (KSHV) has an essential role in viral latent infection. LNA maintains the stability of KSHV episomes and modulates the expression of cellular genes. A novel cellular protein KLIP1 was identified to interact with LNA through yeast two-hybrid screening, and confirmed by a glutathione S-transferase pull down assay. Domain mapping showed that KLIP1 interacted with the N-terminal domain of LNA. Northern blot hybridization with a KLIP1 probe identified a major transcript of 1.8 kb and a minor transcript of 2.8 kb. cDNA library screening and 5'-RACE revealed that the major transcript encoded an open-reading-frame of 1,257 bp and had a 5'-untranslated region of 73 nucleotides. The major KLIP1 transcript was ubiquitously present in different cell types examined. A KLIP1 synthetic peptide antibody detected a doublet of 58-kDa and 63-kDa proteins in a Western blot assay. KLIP1 had two putative nuclear localization signals and showed punctate nuclear localization when expressed as a GFP-fusion protein. KLIP1 interacted with LNA in vivo, as demonstrated by coimmunoprecipitation using KSHV-infected cells and colocalization when they were expressed as GFP- and DsRed-fusion proteins, respectively. Consistent with its interaction with LNA, nuclear localization, and possession of two leucine zipper motifs, KLIP1 behaved like a transcriptional factor and repressed herpes simplex virus thymidine kinase (TK) promoter activity in a mammalian one-hybrid assay. In addition, cotransfection with LNA alleviated the transcriptional repression effect of KLIP1 on TK promoter activity. These results suggest that KLIP1 is a new member of cellular transcriptional repressors, and that LNA is involved in deregulating cellular transcription process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941884      PMCID: PMC224565          DOI: 10.1128/jvi.77.18.9758-9768.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Epstein-Barr virus (EBV) and human disease: facts, opinions and problems.

Authors:  B E Griffin
Journal:  Mutat Res       Date:  2000-04       Impact factor: 2.433

Review 2.  Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.

Authors:  C Boshoff; R A Weiss
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

3.  The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter.

Authors:  J S Knight; M A Cotter; E S Robertson
Journal:  J Biol Chem       Date:  2001-04-19       Impact factor: 5.157

4.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.

Authors:  M E Ballestas; K M Kaye
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen.

Authors:  M E Ballestas; P A Chatis; K M Kaye
Journal:  Science       Date:  1999-04-23       Impact factor: 47.728

6.  Characterization of the promoter region of the viral interferon regulatory factor encoded by Kaposi's sarcoma-associated herpesvirus.

Authors:  X P Wang; Y J Zhang; J H Deng; H Y Pan; F C Zhou; E A Montalvo; S J Gao
Journal:  Oncogene       Date:  2001-01-25       Impact factor: 9.867

Review 7.  Molecular virology of Kaposi's sarcoma-associated herpesvirus.

Authors:  P S Moore; Y Chang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

8.  DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.

Authors:  A C Garber; M A Shu; J Hu; R Renne
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

9.  Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.

Authors:  T S Hyun; C Subramanian; M A Cotter; R A Thomas; E S Robertson
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

10.  The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.

Authors:  C Lim; Y Gwack; S Hwang; S Kim; J Choe
Journal:  J Biol Chem       Date:  2001-06-25       Impact factor: 5.157

View more
  21 in total

Review 1.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

Review 2.  Establishment of the vertebrate kinetochores.

Authors:  Tetsuya Hori; Tatsuo Fukagawa
Journal:  Chromosome Res       Date:  2012-07       Impact factor: 5.239

Review 3.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

4.  The constitutive centromere component CENP-50 is required for recovery from spindle damage.

Authors:  Yukinori Minoshima; Tetsuya Hori; Masahiro Okada; Hiroshi Kimura; Tokuko Haraguchi; Yasushi Hiraoka; Ying-Chun Bao; Toshiyuki Kawashima; Toshio Kitamura; Tatsuo Fukagawa
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

5.  The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer.

Authors:  Shuang-Yan Lin; Yan-Bo Lv; Gen-Xiang Mao; Xu-Jiao Chen; Fang Peng
Journal:  Oncol Lett       Date:  2018-09-21       Impact factor: 2.967

6.  Selective blockade of cancer cell proliferation and anchorage-independent growth by Plk1 activity-dependent suicidal inhibition of its polo-box domain.

Authors:  Jung-Eun Park; Tae-Sung Kim; Bo Yeon Kim; Kyung S Lee
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  TNIP1 is a corepressor of agonist-bound PPARs.

Authors:  Anthony M Flores; Igor Gurevich; Carmen Zhang; Vincent P Ramirez; Taylor R Devens; Brian J Aneskievich
Journal:  Arch Biochem Biophys       Date:  2011-09-22       Impact factor: 4.013

8.  Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence.

Authors:  Feng-Chun Ye; Fu-Chun Zhou; Seung Min Yoo; Jian-Ping Xie; Philip J Browning; Shou-Jiang Gao
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program.

Authors:  Qiuhua Li; Fuchun Zhou; Fengchun Ye; Shou-Jiang Gao
Journal:  Virology       Date:  2008-08-05       Impact factor: 3.616

Review 10.  Chromatin organization of gammaherpesvirus latent genomes.

Authors:  Italo Tempera; Paul M Lieberman
Journal:  Biochim Biophys Acta       Date:  2009-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.